Rockville, Oct. 14, 2022 (GLOBE NEWSWIRE) -- As of 2022, the global cartilage degeneration market is valued at US$ 12.1 billion and is estimated to escalate to a valuation of US$ 16 billion by the end of 2027. The global market is projected to evolve at a CAGR of 5.7% over the next five years.
Rising number of accidents and sports injuries has resulted in an increased incidence of bone disorders, which is expected to primarily influence cartilage degeneration market growth potential positively over the coming years. Growing aging population, rising obesity, adoption of advanced technologies in cartilage repair, supportive government initiatives, increased healthcare expenditure, and rising investments in healthcare R&D are other factors that are predicted to drive cartilage degeneration market growth throughout the forecast period.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=7738
Key providers of cartilage degeneration treatment are adopting strategies such as mergers, collaborations, and acquisitions to bolster their market presence on a global scale.
- In January 2021, Stryker Corporation, a multinational medical technology organization, announced the acquisition of OrthoSensor Inc., a leading name in musculoskeletal care and sensor technology for total joint replacements. With this acquisition, Stryker has strengthened its orthopedics product portfolio.
Key Takeaways from Market Study
- The global cartilage degeneration market is currently valued at US$ 12.1 billion.
- From 2022 to 2027, demand for cartilage degeneration treatment is set to mature at a steady 5.7% CAGR.
- By 2027, revenue from the cartilage degeneration market is expected to reach US$ 16 million.
- In 2022, the United States cartilage degeneration market enjoys a valuation of US$ 3.4 billion.
- Growing senescent population, rising obesity, increasing incidence of accidents, and rising number of sports injuries are prime factors that will drive cartilage degeneration market expansion.
- High costs of joint surgeries and lack of reimbursement policies in most countries are expected to have a restraining effect on market growth potential.
- The market in China is slated to progress at 6% CAGR and attain a valuation of US$ 2.8 billion by 2027-end.
- Demand for joint replacement procedures is anticipated to rise at 6% CAGR and end up with a revenue of US$ 5.7 billion by 2027.
“Rising geriatric population across the world is expected to be essential to overall cartilage degeneration market development over the next five years,” says a Fact.MR analyst
Need an Exclusive Report for Your Unique Requirement, Enquiry Now! – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7738
Key Segments in Cartilage Degeneration Industry Research
- By Procedure:
- Joint Replacements
- Chondroplasty
- Osteochondral Transplants
- Microfracture
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Autologous Chondrocyte Implantation
- Others
- By Application:
- Knees
- Hips
- Others
- By Treatment Delivery Channel:
- Hospitals
- Academic & Research Institutes
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report- https://www.factmr.com/checkout/7738
Winning Strategy
Key companies in the cartilage degeneration market are expected to focus on the research and development of novel products that repair cartilage damage caused by degeneration. Companies are expected to push for approvals of new therapies and treatments for cartilage repair and regeneration from regulatory bodies such as the FDA.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global cartilage degeneration market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.
The study divulges essential insights on the market on the basis of procedure (joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, autologous chondrocyte implantation, others), application (knees, hips, others), and treatment delivery channel (hospitals, academic & research institutes, specialty clinics, ambulatory surgical centers, others), across six major regions (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).
Check out more related studies published by Fact.MR Research:
Knee Cartilage Repair Market: The global knee cartilage repair market is predicted to evolve at a CAGR of 5% from 2022 to 2027. In 2022, the market stands at a valuation of US$ 3.92 billion and is expected to reach US$ 5 billion by the end of 2027. The U.S., China, and Canada are expected to be highly lucrative markets for knee cartilage repair over the next five years.
Sacroiliac Joint Fusion Market: The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.
Meniscus Repair Systems Market: Meniscus repair systems is a device intended for use in meniscal repairs and meniscal allograft transplant procedures such as insertion, anchoring or suturing the allograft to the meniscal rim during transplant procedures. A meniscus transplant or repair surgery is performed to repair or replace the damaged or diseased meniscus of the knee.
Autologous Fat Grafting Market: The global autologous fat grafting market is projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%. Fact.MR, in its revised research report, tracks the global sales of autologous fat grafting in 20+ high-growth markets, with North America and Europe the largest regional markets.
Preimplantation Genetic Testing Market: The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2031. Increasing prevalence of genetic disorders is broadening growth prospects.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Tel: +1 (628) 251-1583
